Zidovudine resistance is suppressed by mutations conferring resistance of human immunodeficiency virus type 1 to foscarnet.

Zidovudine resistance is suppressed by mutations conferring resistance of human immunodeficiency virus type 1 to foscarnet.

Item
http://www.wikidata.org/entity/Q35870930
Transcription inhibition by the depsipeptide antibiotic salinamide AA new point mutation (P157S) in the reverse transcriptase of human immunodeficiency virus type 1 confers low-level resistance to (-)-beta-2',3'-dideoxy-3'-thiacytidineIn vitro selection of mutations in the human immunodeficiency virus type 1 reverse transcriptase that decrease susceptibility to (-)-beta-D-dioxolane-guanosine and suppress resistance to 3'-azido-3'-deoxythymidineAlkylglycerol prodrugs of phosphonoformate are potent in vitro inhibitors of nucleoside-resistant human immunodeficiency virus type 1 and select for resistance mutations that suppress zidovudine resistanceCoresistance to zidovudine and foscarnet is associated with multiple mutations in the human immunodeficiency virus type 1 reverse transcriptase.N348I in the connection domain of HIV-1 reverse transcriptase confers zidovudine and nevirapine resistanceThe Role of Nucleotide Excision by Reverse Transcriptase in HIV Drug Resistance.Reverse transcriptase in motion: conformational dynamics of enzyme-substrate interactions.Reversion of the M184V mutation in simian immunodeficiency virus reverse transcriptase is selected by tenofovir, even in the presence of lamivudine.Relationship between 3'-azido-3'-deoxythymidine resistance and primer unblocking activity in foscarnet-resistant mutants of human immunodeficiency virus type 1 reverse transcriptase.Thymidine analogue resistance suppression by V75I of HIV-1 reverse transcriptase: effects of substituting valine 75 on stavudine excision and discrimination.The glutamine side chain at position 91 on the β5a-β5b loop of human immunodeficiency virus type 1 reverse transcriptase is required for stabilizing the dNTP binding pocket.Pressure of zidovudine accelerates the reversion of lamivudine resistance-conferring M184V mutation in the reverse transcriptase of human immunodeficiency virus type 1.Structural Aspects of Drug Resistance and Inhibition of HIV-1 Reverse Transcriptase.Conformational States of HIV-1 Reverse Transcriptase for Nucleotide Incorporation vs Pyrophosphorolysis-Binding of Foscarnet.In vitro human immunodeficiency virus type 1 resistance selections with combinations of tenofovir and emtricitabine or abacavir and lamivudine.Hypersusceptibility to substrate analogs conferred by mutations in human immunodeficiency virus type 1 reverse transcriptase.
P2860

Zidovudine resistance is suppressed by mutations conferring resistance of human immunodeficiency virus type 1 to foscarnet.

Item
http://www.wikidata.org/entity/Q35870930
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Zidovudine resistance is suppr ...... ncy virus type 1 to foscarnet.
@ast
Zidovudine resistance is suppr ...... ncy virus type 1 to foscarnet.
@en
type
label
Zidovudine resistance is suppr ...... ncy virus type 1 to foscarnet.
@ast
Zidovudine resistance is suppr ...... ncy virus type 1 to foscarnet.
@en
prefLabel
Zidovudine resistance is suppr ...... ncy virus type 1 to foscarnet.
@ast
Zidovudine resistance is suppr ...... ncy virus type 1 to foscarnet.
@en
P1433
P1476
P2093
P2860
P304
P31
P407
P433
P478
P50
P577
P698
P932
P1433
P1476
Zidovudine resistance is suppr ...... ency virus type 1 to foscarnet
@en
P2093
P2860
P304
P31
P407
P433
P478
P50
P577
P698
P932